Response of transposable elements to environmental stressors

Mutation Research - Reviews in Mutation Research

Volumn 765, Issue , 2015, Pages 19-39

  Miousse, Isabelle R ^a   Chalbot, Marie Cecile G ^a   Lumen, Annie ^b   Ferguson, Alesia ^a   Kavouras, Ilias G ^a   Koturbash, Igor ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Air pollution; DNA methylation; Environmental stressors; Ionizing radiation; Metals; Retrotransposition

Indexed keywords

1,3 BUTADIENE; ARSENIC; BENZENE; BENZO[A]PYRENE; CADMIUM; LEAD; MERCURY; TOBACCO SMOKE; BIOLOGICAL MARKER; POLLUTANT; TRANSPOSON;

AIR POLLUTION; COSMIC RADIATION; DNA METHYLATION; ENVIRONMENTAL RADIOACTIVITY; ENVIRONMENTAL STRESS; EXHAUST GAS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC REGULATION; HISTONE MODIFICATION; HUMAN; IONIZING RADIATION; LIGHT; LONG INTERSPERSED REPEAT; LONG TERMINAL REPEAT; NEXT GENERATION SEQUENCING; NONHUMAN; OPEN READING FRAME; PARTICULATE MATTER; PERSISTENT ORGANIC POLLUTANT; PRIORITY JOURNAL; PROTON RADIATION; PYROSEQUENCING; RADIATION EXPOSURE; RESTRICTION MAPPING; RETROPOSON; REVIEW; RISK ASSESSMENT; SHORT INTERSPERSED REPEAT; TRAFFIC; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TRANSPOSON; ULTRAVIOLET RADIATION; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; METABOLISM; NEOPLASMS; POLLUTANT; RADIATION RESPONSE; TOXICITY;

BIOMARKERS; DNA METHYLATION; DNA TRANSPOSABLE ELEMENTS; ENVIRONMENTAL POLLUTANTS; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS;

EID: 84939463800     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2015.05.003     Document Type: Review

References (249)

1. de Koning A.P., Gu W., Castoe T.A., Batzer M.A., Pollock D.D. Repetitive elements may comprise over two-thirds of the human genome. PLoS Genet. 2011, 7:e1002384.
2. Chenais B., Caruso A., Hiard S., Casse N. The impact of transposable elements on eukaryotic genomes: from genome size increase to genetic adaptation to stressful environments. Gene 2012, 509:7-15.
3. Ostertag E.M., Kazazian H.H. Biology of mammalian L1 retrotransposons. Annu. Rev. Genet. 2001, 35:501-538.
4. Burns K.H., Boeke J.D. Human transposon tectonics. Cell 2012, 149:740-752.
5. Rebollo R., Romanish M.T., Mager D.L. Transposable elements: an abundant and natural source of regulatory sequences for host genes. Annu. Rev. Genet. 2012, 46:21-42.
6. Cowley M., Oakey R.J. Transposable elements re-wire and fine-tune the transcriptome. PLoS Genet. 2013, 9:e1003234.
7. Belan E. LINEs of evidence: noncanonical DNA replication as an epigenetic determinant. Biol. Direct 2013, 8:22.
8. Jurka J., Kapitonov V.V., Kohany O., Jurka M.V. Repetitive sequences in complex genomes: structure and evolution. Annu. Rev. Genomics Hum. Genet. 2007, 8:241-259.
9. Faulkner G.J. Retrotransposons: mobile and mutagenic from conception to death. FEBS Lett. 2011, 585:1589-1594.
10. Kaer K., Speek M. Retroelements in human disease. Gene 2013, 518:231-241.
11. Feng Q., Moran J.V., Kazazian H.H., Boeke J.D. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 1996, 87:905-916.
12. Cost G.J., Feng Q., Jacquier A., Boeke J.D. Human L1 element target-primed reverse transcription in vitro. EMBO J. 2002, 21:5899-5910.
13. Tchenio T., Casella J.F., Heidmann T. Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res. 2000, 28:411-415.
14. Yang N., Zhang L., Zhang Y., Kazazian H.H. An important role for RUNX3 in human L1 transcription and retrotransposition. Nucleic Acids Res. 2003, 31:4929-4940.
15. Harris C.R., Dewan A., Zupnick A., Normart R., Gabriel A., Prives C., Levine A.J., Hoh J. p53 responsive elements in human retrotransposons. Oncogene 2009, 28:3857-3865.
16. Matlik K., Redik K., Speek M. L1 antisense promoter drives tissue-specific transcription of human genes. J Biomed. Biotechnol. 2006, 2006:71753.
17. Cruickshanks H.A., Vafadar-Isfahani N., Dunican D.S., Lee A., Sproul D., Lund J.N., Meehan R.R., Tufarelli C. Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer. Nucleic Acids Res. 2013, 41:6857-6869.
18. Yang N., Kazazian H.H. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat. Struct. Mol. Biol. 2006, 13:763-771.
19. Li J., Kannan M., Trivett A.L., Liao H., Wu X., Akagi K., Symer D.E. An antisense promoter in mouse L1 retrotransposon open reading frame-1 initiates expression of diverse fusion transcripts and limits retrotransposition. Nucleic Acids Res. 2014, 42:4546-4562.
20. Huang C.R., Burns K.H., Boeke J.D. Active transposition in genomes. Annu. Rev. Genet. 2012, 46:651-675.
21. Alexandrova E.A., Olovnikov I.A., Malakhova G.V., Zabolotneva A.A., Suntsova M.V., Dmitriev S.E., Buzdin A.A. Sense transcripts originated from an internal part of the human retrotransposon LINE-1 5' UTR. Gene 2012, 511:46-53.
22. Kulpa D.A., Moran J.V. Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat. Struct. Mol. Biol. 2006, 13:655-660.
23. Kazazian H.H. Mobile elements: drivers of genome evolution. Science 2004, 303:1626-1632.
24. Goodier J.L., Kazazian H.H. Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell 2008, 135:23-35.
25. Trelogan S.A., Martin S.L. Tightly regulated, developmentally specific expression of the first open reading frame from LINE-1 during mouse embryogenesis. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1520-1524.
26. Kano H., Godoy I., Courtney C., Vetter M.R., Gerton G.L., Ostertag E.M., Kazazian H.H. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev. 2009, 23:1303-1312.
27. Martin S.L., Li W.L., Furano A.V., Boissinot S. The structures of mouse and human L1 elements reflect their insertion mechanism. Cytogenet. Genome Res. 2005, 110:223-228.
28. McCarthy E.M., McDonald J.F. Long terminal repeat retrotransposons of mus musculus. Genome Biol. 2004, 5:R14.
29. Mills R.E., Bennett E.A., Iskow R.C., Devine S.E. Which transposable elements are active in the human genome?. Trends Genet. 2007, 23:183-191.
30. Zhang Y., Maksakova I.A., Gagnier L., van d.L., Mager D.L. Genome-wide assessments reveal extremely high levels of polymorphism of two active families of mouse endogenous retroviral elements. PLoS Genet. 2008, 4:e1000007.
31. Malik H.S., Burke W.D., Eickbush T.H. The age and evolution of non-LTR retrotransposable elements. Mol. Biol. Evol. 1999, 16:793-805.
32. Smit A.F. Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr. Opin. Genet. Dev. 1999, 9:657-663.
33. Batzer M.A., Deininger P.L. Alu repeats and human genomic diversity. Nat. Rev. Genet. 2002, 3:370-379.
34. Cordaux R., Hedges D.J., Herke S.W., Batzer M.A. Estimating the retrotransposition rate of human alu elements. Gene 2006, 373:134-137.
35. Luo Y., Lu X., Xie H. Dynamic alu methylation during normal development, aging, and tumorigenesis. Biomed. Res Int. 2014, 2014:784706.
36. Dewannieux M., Esnault C., Heidmann T. LINE-mediated retrotransposition of marked alu sequences. Nat. Genet. 2003, 35:41-48.
37. Walters R.D., Kugel J.F., Goodrich J.A. InvAluable junk: the cellular impact and function of alu and B2 RNAs. IUBMB Life 2009, 61:831-837.
38. Yakovchuk P., Goodrich J.A., Kugel J.F. B2 RNA and alu RNA repress transcription by disrupting contacts between RNA polymerase II and promoter DNA within assembled complexes. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5569-5574.
39. Roman A.C., Gonzalez-Rico F.J., Fernandez-Salguero P.M. B1-SINE retrotransposons: establishing genomic insulatory networks. Mob. Genet Elements 2011, 1:66-70.
40. Estecio M.R., Gallegos J., Dekmezian M., Lu Y., Liang S., Issa J.P. SINE retrotransposons cause epigenetic reprogramming of adjacent gene promoters. Mol. Cancer Res. 2012, 10:1332-1342.
41. Schläppi M., Raina R., Fedoroff N. Epigenetic regulation of the maize spm transposable element: novel activation of a methylated promoter by TnpA. Cell 1994, 77:427-437.
42. Ross J.P., Rand K.N., Molloy P.L. Hypomethylation of repeated DNA sequences in cancer. Epigenomics 2010, 2:245-269.
43. Jones P.A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 2012, 13:484-492.
44. Byun H.M., Motta V., Panni T., Bertazzi P.A., Apostoli P., Hou L., Baccarelli A.A. Evolutionary age of repetitive element subfamilies and sensitivity of DNA methylation to airborne pollutants. Part. Fibre Toxicol. 2013, 10:28.
45. Miousse I.R., Koturbash I. The fine LINE: methylation drawing the cancer landscape. BioMed Res. Int. 2015.
46. Yoder J.A., Walsh C.P., Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 1997, 13:335-340.
47. Bourc'his D., Bestor T.H. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 2004, 431:96-99.
48. Leung D.C., Lorincz M.C. Silencing of endogenous retroviruses: when and why do histone marks predominate?. Trends Biochem. Sci. 2012, 37:127-133.
49. Macia A., Muñoz-Lopez M., Cortes J.L., Hastings R.K., Morell S., Lucena-Aguilar G., Marchal J.A., Badge R.M., Garcia-Perez J.L. Epigenetic control of retrotransposon expression in human embryonic stem cells. Mol. Cell. Biol. 2011, 31:300-316.
50. Martens J.H., O'Sullivan R.J., Braunschweig U., Opravil S., Radolf M., Steinlein P., Jenuwein T. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 2005, 24:800-812.
51. Karimi M.M., Goyal P., Maksakova I.A., Bilenky M., Leung D., Tang J.X., Shinkai Y., Mager D.L., Jones S., Hirst M., Lorincz M.C. DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell 2011, 8:676-687.
52. Rangasamy D. Distinctive patterns of epigenetic marks are associated with promoter regions of mouse LINE-1 and LTR retrotransposons. Mob. DNA 2013, 4:27.
53. Carmell M.A., Girard A., van d.K., Bourc'his D., Bestor T.H., de Rooij D.G., Hannon G.J. MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev. Cell 2007, 12:503-514.
54. De Fazio S., Bartonicek N., Di G.M., Abreu-Goodger C., Sankar A., Funaya C., Antony C., Moreira P.N., Enright A.J., O'Carroll D. The endonuclease activity of mili fuels piRNA amplification that silences LINE1 elements. Nature 2011, 480:259-263.
55. Rodic N., Sharma R., Sharma R., Zampella J., Dai L., Taylor M.S., Hruban R.H., Iacobuzio-Donahue C.A., Maitra A., Torbenson M.S., Goggins M., Shih I., Duffield A.S., Montgomery E.A., Gabrielson E., Netto G.J., Lotan T.L., De Marzo A.M., Westra W., Binder Z.A., Orr B.A., Gallia G.L., Eberhart C.G., Boeke J.D., Harris C.R., Burns K.H. Long interspersed element-1 protein expression is a hallmark of many human cancers. Am. J. Pathol. 2014, 184:1280-1286.
56. Boyle A.L., Ballard S.G., Ward D.C. Differential distribution of long and short interspersed element sequences in the mouse genome: chromosome karyotyping by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:7757-7761.
57. Han J.S., Szak S.T., Boeke J.D. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 2004, 429:268-274.
58. Muotri A.R., Chu V.T., Marchetto M.C., Deng W., Moran J.V., Gage F.H. Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature 2005, 435:903-910.
59. Faulkner G.J., Kimura Y., Daub C.O., Wani S., Plessy C., Irvine K.M., Schroder K., Cloonan N., Steptoe A.L., Lassmann T., Waki K., Hornig N., Arakawa T., Takahashi H., Kawai J., Forrest A.R., Suzuki H., Hayashizaki Y., Hume D.A., Orlando V., Grimmond S.M., Carninci P. The regulated retrotransposon transcriptome of mammalian cells. Nat. Genet. 2009, 41:563-571.
60. Wolff E.M., Byun H.M., Han H.F., Sharma S., Nichols P.W., Siegmund K.D., Yang A.S., Jones P.A., Liang G. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet. 2010, 6:e1000917.
61. Hur K., Cejas P., Feliu J., Moreno-Rubio J., Burgos E., Boland C.R., Goel A. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut 2014, 63:635-646.
62. Miki Y., Nishisho I., Horii A., Miyoshi Y., Utsunomiya J., Kinzler K.W., Vogelstein B., Nakamura Y. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 1992, 52:643-645.
63. Iskow R.C., McCabe M.T., Mills R.E., Torene S., Pittard W.S., Neuwald A.F., Van Meir E.G., Vertino P.M., Devine S.E. Natural mutagenesis of human genomes by endogenous retrotransposons. Cell 2010, 141:1253-1261.
64. Lee E., Iskow R., Yang L., Gokcumen O., Haseley P., Luquette L.J., Lohr J.G., Harris C.C., Ding L., Wilson R.K., Wheeler D.A., Gibbs R.A., Kucherlapati R., Lee C., Kharchenko P.V., Park P.J. Landscape of somatic retrotransposition in human cancers. Science 2012, 337:967-971.
65. Solyom S., Ewing A.D., Rahrmann E.P., Doucet T., Nelson H.H., Burns M.B., Harris R.S., Sigmon D.F., Casella A., Erlanger B., Wheelan S., Upton K.R., Shukla R., Faulkner G.J., Largaespada D.A., Kazazian H.H. Extensive somatic L1 retrotransposition in colorectal tumors. Genome Res. 2012, 22:2328-2338.
66. Kazazian H.H., Wong C., Youssoufian H., Scott A.F., Phillips D.G., Antonarakis S.E. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 1988, 332:164-166.
67. Beck C.R., Garcia-Perez J.L., Badge R.M., Moran J.V. LINE-1 elements in structural variation and disease. Annu. Rev. Genomics Hum. Genet. 2011, 12:187-215.
68. Hancks D.C., Kazazian H.H. Active human retrotransposons: variation and disease. Curr. Opin. Genet. Dev. 2012, 22:191-203.
69. Rangwala S.H., Kazazian H.H. The L1 retrotransposition assay: a retrospective and toolkit. Methods 2009, 49:219-226.
70. Ewing A.D., Kazazian H.H. High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res. 2010, 20:1262-1270.
71. Stewart C., Kural D., Strömberg M.P., Walker J.A., Konkel M.K., Sttz A.M., Urban A.E., Grubert F., Lam H.Y., Lee W.P., Busby M., Indap A.R., Garrison E., Huff C., Xing J., Snyder M.P., Jorde L.B., Batzer M.A., Korbel J.O., Marth G.T. A comprehensive map of mobile element insertion polymorphisms in humans. PLoS Genet. 2011, 7:e1002236.
72. Witherspoon D.J., Xing J., Zhang Y., Watkins W.S., Batzer M.A., Jorde L.B. Mobile element scanning (ME-scan) by targeted high-throughput sequencing. BMC Genomics 2010, 11:410.
73. White T.B., McCoy A.M., Streva V.A., Fenrich J., Deininger P.L. A droplet digital PCR detection method for rare L1 insertions in tumors. Mob. DNA 2014, 5:30.
74. Helman E., Lawrence M.S., Stewart C., Sougnez C., Getz G., Meyerson M. Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing. Genome Res. 2014, 24:1053-1063.
75. Criscione S.W., Zhang Y., Thompson W., Sedivy J.M., Neretti N. Transcriptional landscape of repetitive elements in normal and cancer human cells. BMC Genomics 2014, 15:583.
76. Mir A.A., Philippe C., Cristofari G. euL1db: the European database of L1HS retrotransposon insertions in humans. Nucleic Acids Res. 2015, 43:D43-D47.
77. Brenner D.J., Mossman K.L. Do radiation doses below 1 cGy increase cancer risks?. Radiat. Res. 2005, 163:692-693.
78. Hall E.J., Brenner D.J. Cancer risks from diagnostic radiology: the impact of new epidemiological data. Br. J. Radiol. 2012, 85:e1316-e1317.
79. American Cancer Society Cancer Facts and Figures 2003, 1-52. American Cancer Society.
80. Brenner D.J. Slowing the increase in the population dose resulting from CT scans. Radiat. Res. 2010, 174:809-815.
81. Malone J., Guleria R., Craven C., Horton P., Järvinen H., Mayo J., O'reilly G., Picano E., Remedios D., Le Heron J., Rehani M., Holmberg O., Czarwinski R. Justification of diagnostic medical exposures: some practical issues. Report of an international atomic energy agency consultation. Br. J. Radiol. 2012, 85:523-538.
82. Lyon C.M., Klinge D.M., Liechty K.C., Gentry F.D., March T.H., Kang T., Gilliland F.D., Adamova G., Rusinova G., Telnov V., Belinsky S.A. Radiation-induced lung adenocarcinoma is associated with increased frequency of genes inactivated by promoter hypermethylation. Radiat. Res. 2007, 168:409-414.
83. Tawa R., Kimura Y., Komura J., Miyamura Y., Kurishita A., Sasaki M.S., Sakurai H., Ono T. Effects of X-ray irradiation on genomic DNA methylation levels in mouse tissues. J. Radiat. Res. 1998, 39:271-278.
84. Pogribny I., Raiche J., Slovack M., Kovalchuk O. Dose-dependence, sex- and tissue-specificity, and persistence of radiation-induced genomic DNA methylation changes. Biochem. Biophys. Res. Commun. 2004, 320:1253-1261.
85. Koturbash I., Pogribny I., Kovalchuk O. Stable loss of global DNA methylation in the radiation-target tissue - a possible mechanism contributing to radiation carcinogenesis?. Biochem. Biophys. Res. Commun. 2005, 337:526-533.
86. Pogribny I., Koturbash I., Tryndyak V., Hudson D., Stevenson S.M., Sedelnikova O., Bonner W., Kovalchuk O. Fractionated low-dose radiation exposure leads to accumulation of DNA damage and profound alterations in DNA and histone methylation in the murine thymus. Mol. Cancer Res. 2005, 3:553-561.
87. Loree J., Koturbash I., Kutanzi K., Baker M., Pogribny I., Kovalchuk O. Radiation-induced molecular changes in rat mammary tissue: possible implications for radiation-induced carcinogenesis. Int. J. Radiat. Biol. 2006, 82:805-815.
88. Giotopoulos G., McCormick C., Cole C., Zanker A., Jawad M., Brown R., Plumb M. DNA methylation during mouse hemopoietic differentiation and radiation-induced leukemia. Exp. Hematol. 2006, 34:1462-1470.
89. Koturbash I., Kutanzi K., Hendrickson K., Rodriguez-Juarez R., Kogosov D., Kovalchuk O. Radiation-induced bystander effects in vivo are sex specific. Mutat. Res. 2008, 642:28-36.
90. Wang J., Zhang Y., Xu K., Mao X., Xue L., Liu X., Yu H., Chen L., Chu X. Genome-wide screen of DNA methylation changes induced by low dose X-ray radiation in mice. PLOS ONE 2014, 9:e90804.
91. Koturbash I., Boyko A., Rodriguez-Juarez R., McDonald R.J., Tryndyak V.P., Kovalchuk I., Pogribny I.P., Kovalchuk O. Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo. Carcinogenesis 2007, 28:1831-1838.
92. 56Fe ion irradiation induces tissue-specific changes in DNA methylation in the mouse. Environ. Mol. Mutagen. 2014, 55:266-277.
93. Miousse I.R., Shao L., Chang J., Feng W., Wang Y., Allen A.R., Turner J., Stewart B., Raber J., Zhou D., Koturbash I. Exposure to low-dose (56)Fe-ion radiation induces long-term epigenetic alterations in mouse bone marrow hematopoietic progenitor and stem cells. Radiat. Res. 2014, 182:92-101.
94. Nzabarushimana E., Miousse I.R., Shao L., Chang J., Allen A.R., Turner J., Stewart B., Raber J., Koturbash I. Long-term epigenetic effects of exposure to low doses of 56Fe in the mouse lung. J. Radiat. Res. 2014, 55:823-828.
95. Aypar U., Morgan W.F., Baulch J.E. Radiation-induced epigenetic alterations after low and high LET irradiations. Mutat. Res. 2011, 707:24-33.
96. Goetz W., Morgan M.N., Baulch J.E. The effect of radiation quality on genomic DNA methylation profiles in irradiated human cell lines. Radiat. Res. 2011, 175:575-587.
97. Lahtz C., Bates S.E., Jiang Y., Li A.X., Wu X., Hahn M.A., Pfeifer G.P. Gamma irradiation does not induce detectable changes in DNA methylation directly following exposure of human cells. PLoS ONE 2012, 7:e44858.
98. Newman M.R., Sykes P.J., Blyth B.J., Bezak E., Lawrence M.D., Morel K.L., Ormsby R.J. A single whole-body low dose X-irradiation does not affect L1, B1 and IAP repeat element DNA methylation longitudinally. PLOS ONE 2014, 9:e93016.
99. Newman M.R., Sykes P.J., Blyth B.J., Bezak E., Lawrence M.D., Morel K.L., Ormsby R.J. The methylation of DNA repeat elements is sex-dependent and temporally different in response to X radiation in radiosensitive and radioresistant mouse strains. Radiat. Res. 2014, 181:65-75.
100. Blakely E.A., Kronenberg A. Heavy-ion radiobiology: new approaches to delineate mechanisms underlying enhanced biological effectiveness. Radiat. Res. 1998, 150:S126-S145.
101. Weil M.M., Bedford J.S., Bielefeldt-Ohmann H., Ray F.A., Genik P.C., Ehrhart E.J., Fallgren C.M., Hailu F., Battaglia C.L., Charles B., Callan M.A., Ullrich R.L. Incidence of acute myeloid leukemia and hepatocellular carcinoma in mice irradiated with 1GeV/nucleon (56)fe ions. Radiat. Res. 2009, 172:213-219.
102. 56Fe ions, and protons on the induction of murine acute myeloid leukemia and hepatocellular carcinoma. PLOS ONE 2014, 9:e104819.
103. Herceg Z., Paliwal A. Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome. Mutat. Res. 2011, 727:55-61.
104. Christofidou-Solomidou M., Pietrofesa R.A., Arguiri E., Schweitzer K.S., Berdyshev E.V., McCarthy M., Corbitt A., Alwood J.S., Yu Y., Globus R.K., Solomides C.C., Ullrich R.L., Petrache I. Space radiation associated lung injury in a murine model. Am. J. Physiol. Lung Cell. Mol. Physiol. 2014, 308:L416-L428.
105. Kroeger H., Jelinek J., Estecio M.R., He R., Kondo K., Chung W., Zhang L., Shen L., Kantarjian H.M., Bueso-Ramos C.E., Issa J.P. Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse. Blood 2008, 112:1366-1373.
106. Bujko M., Musialik E., Olbromski R., Przestrzelska M., Libura M., Pastwinska A., Juszczynski P., Zwierzchowski L., Baranowski P., Siedlecki J.A. Repetitive genomic elements and overall DNA methylation changes in acute myeloid and childhood B-cell lymphoblastic leukemia patients. Int. J. Hematol. 2014, 100:79-87.
107. Tanaka A., Nakatani Y., Hamada N., Jinno-Oue A., Shimizu N., Wada S., Funayama T., Mori T., Islam S., Hoque S.A., Shinagawa M., Ohtsuki T., Kobayashi Y., Hoshino H. Ionising irradiation alters the dynamics of human long interspersed nuclear elements 1 (LINE1) retrotransposon. Mutagenesis 2012, 27:599-607.
108. Banaz-Yasar F., Gedik N., Karahan S., Diaz-Carballo D., Bongartz B.M., Ergün S. LINE-1 retrotransposition events regulate gene expression after X-ray irradiation. DNA Cell Biol. 2012, 31:1458-1467.
109. Jonason A.S., Kunala S., Price G.J., Restifo R.J., Spinelli H.M., Persing J.A., Leffell D.J., Tarone R.E., Brash D.E. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:14025-14029.
110. Ichihashi M., Ueda M., Budiyanto A., Bito T., Oka M., Fukunaga M., Tsuru K., Horikawa T. UV-induced skin damage. Toxicology 2003, 189:21-39.
111. Zhang W., Hanks A.N., Boucher K., Florell S.R., Allen S.M., Alexander A., Brash D.E., Grossman D. UVB-induced apoptosis drives clonal expansion during skin tumor development. Carcinogenesis 2005, 26:249-257.
112. Banerjee G., Gupta N., Tiwari J., Raman G. Ultraviolet-induced transformation of keratinocytes: possible involvement of long interspersed element-1 reverse transcriptase. Photodermatol. Photoimmunol. Photomed. 2005, 21:32-39.
113. Teneng I., Stribinskis V., Ramos K.S. Context-specific regulation of LINE-1. Genes Cells. 2007, 12:1101-1110.
114. Nair-Shalliker V., Dhillon V., Clements M., Armstrong B.K., Fenech M. The association between personal sun exposure, serum vitamin D and global methylation in human lymphocytes in a population of healthy adults in south australia. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2014, 765C:6-10.
115. Serafino A., Balestrieri E., Pierimarchi P., Matteucci C., Moroni G., Oricchio E., Rasi G., Mastino A., Spadafora C., Garaci E., Vallebona P.S. The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Exp. Cell Res. 2009, 315:849-862.
116. Stengel S., Fiebig U., Kurth R., Denner J. Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation. Genes Chromosomes Cancer 2010, 49:401-411.
117. Muster T., Waltenberger A., Grassauer A., Hirschl S., Caucig P., Romirer I., Födinger D., Seppele H., Schanab O., Magin-Lachmann C., Löwer R., Jansen B., Pehamberger H., Wolff K. An endogenous retrovirus derived from human melanoma cells. Cancer Res. 2003, 63:8735-8741.
118. Schmitt K., Reichrath J., Roesch A., Meese E., Mayer J. Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma. Genome Biol Evol. 2013, 5:307-328.
119. Reiche J., Pauli G., Ellerbrok H. Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation. Melanoma Res. 2010, 20:435-440.
120. Schanab O., Humer J., Gleiss A., Mikula M., Sturlan S., Grunt S., Okamoto I., Muster T., Pehamberger H., Waltenberger A. Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma. Pigment Cell Melanoma Res. 2011, 24:656-665.
121. Brunekreef B., Holgate S.T. Air pollution and health. Lancet 2002, 360:1233-1242.
122. Dockery D.W., Pope C.A., Xu X., Spengler J.D., Ware J.H., Fay M.E., Ferris B.G., Speizer F.E. An association between air pollution and mortality in six U.S. cities. N. Engl. J. Med. 1993, 329:1753-1759.
123. Jarup L. Hazards of heavy metal contamination. Br. Med. Bull. 2003, 68:167-182.
124. Pope C.A. Epidemiology of fine particulate air pollution and human health: biologic mechanisms and who's at risk?. Environ. Health Perspect. 2000, 108(Suppl. 4):713-723.
125. Demerjian K.L., Mohnen V.A. Synopsis of the temporal variation of particulate matter composition and size. J. Air Waste Manag. Assoc. 2008, 58:216-233.
126. Brunekreef B., Forsberg B. Epidemiological evidence of effects of coarse airborne particles on health. Eur. Respir. J. 2005, 26:309-318.
127. Delfino R.J., Sioutas C., Malik S. Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ. Health Perspect. 2005, 113:934-946.
128. Sioutas C., Delfino R.J., Singh M. Exposure assessment for atmospheric ultrafine particles (UFPs) and implications in epidemiologic research. Environ. Health Perspect. 2005, 113:947-955.
129. de Hartog J.J., Ayres J.G., Karakatsani A., Analitis A., Brink H.T., Hameri K., Harrison R., Katsouyanni K., Kotronarou A., Kavouras I., Meddings C., Pekkanen J., Hoek G. Lung function and indicators of exposure to indoor and outdoor particulate matter among asthma and COPD patients. Occup. Environ. Med. 2010, 67:2-10.
130. Loomis D., Grosse Y., Lauby-Secretan B.A., El Ghissassi F., Bouvard V.A., Benbrahim-Tallaa L., Guha N., Baan R., Mattock H., Straif K. The carcinogenicity of outdoor air pollution. Lancet Oncol. 2013, 14:1262-1263.
131. Valavanidis A., Fiotakis K., Vlachogianni T. Airborne particulate matter and human health: Toxicological assessment and importance of size and composition of particles for oxidative damage and carcinogenic mechanisms. J. Environ. Sci. Health C: Environ. Carcinog. Ecotoxicol. Rev. 2008, 26:339-362.
132. Akhtar U.S., McWhinney R.D., Rastogi N., Abbatt J.P., Evans G.J., Scott J.A. Cytotoxic and proinflammatory effects of ambient and source-related particulate matter (PM) in relation to the production of reactive oxygen species (ROS) and cytokine adsorption by particles. Inhal. Toxicol. 2010, 22(Suppl 2):37-47.
133. DeMarini D.M. Genotoxicity biomarkers associated with exposure to traffic and near-road atmospheres: a review. Mutagenesis 2013, 28:485-505.
134. Franzi L.M., Bratt J.M., Williams K.M., Last J.A. Why is particulate matter produced by wildfires toxic to lung macrophages?. Toxicol. Appl. Pharmacol. 2011, 257:182-188.
135. Nelson P.F., Tibbett A.R., Day S.J. Effects of vehicle type and fuel quality on real world toxic emissions from diesel vehicles. Atmos. Environ. 2008, 42:5291-5303.
136. Li R., Ning Z., Majumdar R., Cui J., Takabe W., Jen N., Sioutas C., Hsiai T. Ultrafine particles from diesel vehicle emissions at different driving cycles induce differential vascular pro-inflammatory responses: implication of chemical components and NF-kappaB signaling. Part. Fibre Toxicol. 2010, 7:6.
137. Reiss R., Anderson E.L., Cross C.E., Hidy G., Hoel D., McClellan R., Moolgavkar S. Evidence of health impacts of sulfate-and nitrate-containing particles in ambient air. Inhal. Toxicol. 2007, 19:419-449.
138. Peluso M., Bollati V., Munnia A., Srivatanakul P., Jedpiyawongse A., Sangrajrang S., Piro S., Ceppi M., Bertazzi P.A., Boffetta P., Baccarelli A.A. DNA methylation differences in exposed workers and nearby residents of the ma ta phut industrial estate, rayong, thailand. Int. J. Epidemiol. 2012, 41:1753-1760.
139. Tarantini L., Bonzini M., Apostoli P., Pegoraro V., Bollati V., Marinelli B., Cantone L., Rizzo G., Hou L., Schwartz J. Effects of particulate matter on genomic DNA methylation content and iNOS promoter methylation. Environ. Health Perspect. 2009, 117:217.
140. Bellavia A., Urch B., Speck M., Brook R.D., Scott J.A., Albetti B., Behbod B., North M., Valeri L., Bertazzi P.A., Silverman F., Gold D., Baccarelli A.A. DNA hypomethylation, ambient particulate matter, and increased blood pressure: findings from controlled human exposure experiments. J. Am. Heart Assoc. 2013, 2:e000212.
141. Yauk C., Polyzos A., Rowan-Carroll A., Somers C.M., Godschalk R.W., Van Schooten F.J., Berndt M.L., Pogribny I.P., Koturbash I., Williams A., Douglas G.R., Kovalchuk O. Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:605-610.
142. Miousse I.R., Chalbot M.C., Aykin-Burns N., Wang X., Basnakian A., Kavouras I.G., Koturbash I. Epigenetic alterations induced by ambient particulate matter in mouse macrophages. Environ. Mol. Mutagen. 2014, 55:428-435.
143. Adar S.D., Gold D.R., Coull B.A., Schwartz J., Stone P.H., Suh H. Focused exposures to airborne traffic particles and heart rate variability in the elderly. Epidemiology 2007, 18:95-103.
144. Park S.K., O'Neill M.S., Vokonas P.S., Sparrow D., Spiro A., Tucker K.L., Suh H., Hu H., Schwartz J. Traffic-related particles are associated with elevated homocysteine: the VA normative aging study. Am. J. Respir. Crit. Care Med. 2008, 178:283-289.
145. Baccarelli A., Wright R.O., Bollati V., Tarantini L., Litonjua A.A., Suh H.H., Zanobetti A., Sparrow D., Vokonas P.S., Schwartz J. Rapid DNA methylation changes after exposure to traffic particles. Am. J. Respir. Crit. Care Med. 2009, 179:572-578.
146. Madrigano J., Baccarelli A., Mittleman M.A., Wright R.O., Sparrow D., Vokonas P.S., Tarantini L., Schwartz J. Prolonged exposure to particulate pollution, genes associated with glutathione pathways, and DNA methylation in a cohort of older men. Environ. Health Perspect. 2011, 119:977-982.
147. Laden F., Neas L.M., Dockery D.W., Schwartz J. Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ. Health Perspect. 2000, 108:941-947.
148. Ris C. U.S. EPA health assessment for diesel engine exhaust: a review. Inhal. Toxicol. 2007, 19(Suppl. 1):229-239.
149. IARC Diesel and gasoline engine exhausts and some nitroarenes. IARC Monogr. Eval. Carcinog. Risks Hum. 2012, 105:1-714.
150. Jiang R., Jones M.J., Sava F., Kobor M.S., Carlsten C. Short-term diesel exhaust inhalation in a controlled human crossover study is associated with changes in DNA methylation of circulating mononuclear cells in asthmatics. Part. Fibre Toxicol. 2014, 11:71.
151. IARC IARC monographs programme on the evaluation of the carcinogenic risk of chemicals to humans. IARC Monogr. Progr. Eval. Carcinog. Risk Chem. Hum. 1986, 39:13-32.
152. Smith M.T. Advances in understanding benzene health effects and susceptibility. Annu. Rev. Public Health 2010, 31:133-148.
153. Khalade A., Jaakkola M.S., Pukkala E., Jaakkola J.J. Exposure to benzene at work and the risk of leukemia: a systematic review and meta-analysis. Environ. Health. 2010, 9:31.
154. Bollati V., Baccarelli A., Hou L., Bonzini M., Fustinoni S., Cavallo D., Byun H.M., Jiang J., Marinelli B., Pesatori A.C., Bertazzi P.A., Yang A.S. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007, 67:876-880.
155. Fustinoni S., Rossella F., Polledri E., Bollati V., Campo L., Byun H.M., Agnello L., Consonni D., Pesatori A.C., Baccarelli A., Bertazzi P.A. Global DNA methylation and low-level exposure to benzene. Med. Lav. 2012, 103:84-95.
156. Seow W.J., Pesatori A.C., Dimont E., Farmer P.B., Albetti B., Ettinger A.S., Bollati V., Bolognesi C., Roggieri P., Panev T.I., Georgieva T., Merlo D.F., Bertazzi P.A., Baccarelli A.A. Urinary benzene biomarkers and DNA methylation in bulgarian petrochemical workers: study findings and comparison of linear and beta regression models. PLoS ONE 2012, 7:e50471.
157. White W.C. Butadiene production process overview. Chem. Biol. Interact. 2007, 166:10-14.
158. IARC 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monogr. Eval. Carcinog. Risks Hum. 2008, 97:3-471.
159. Cochrane J.E., Skopek T.R. Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 1994, 15:713-717.
160. Koturbash I., Scherhag A., Sorrentino J., Sexton K., Bodnar W., Tryndyak V., Latendresse J.R., Swenberg J.A., Beland F.A., Pogribny I.P., Rusyn I. Epigenetic alterations in liver of C57BL/6J mice after short-term inhalational exposure to 1,3-butadiene. Environ. Health Perspect. 2011, 119:635-640.
161. Koturbash I., Scherhag A., Sorrentino J., Sexton K., Bodnar W., Swenberg J.A., Beland F.A., Pardo-Manuel D.F., Rusyn I., Pogribny I.P. Epigenetic mechanisms of mouse interstrain variability in genotoxicity of the environmental toxicant 1,3-butadiene. Toxicol. Sci. 2011, 122:448-456.
162. Chappell G., Kobets T., O'Brien B., Tretyakova N., Sangaraju D., Kosyk O., Sexton K.G., Bodnar W., Pogribny I.P., Rusyn I. Epigenetic events determine tissue-specific toxicity of inhalational exposure to the genotoxic chemical 1,3-butadiene in male C57BL/6J mice. Toxicol. Sci. 2014, 142:375-384.
163. Walser T., Cui X., Yanagawa J., Lee J.M., Heinrich E., Lee G., Sharma S., Dubinett S.M. Smoking and lung cancer: the role of inflammation. Proc. Am. Thorac. Soc. 2008, 5:811-815.
164. IARC Personal habits and indoor combustions. IARC Monogr. Eval. Carcinog. Risks Hum. 2012, 100E:1-598.
165. Hecht S.S. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 2002, 3:461-469.
166. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat. Res. 2004, 567:447-474.
167. Koturbash I., Beland F.A., Pogribny I.P. Role of epigenetic events in chemical carcinogenesis - a justification for incorporating epigenetic evaluations in cancer risk assessment. Toxicol Mech. Methods. 2011, 21:289-297.
168. Belinsky S.A. Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis 2005, 26:1481-1487.
169. Kim J.S., Kim H., Shim Y.M., Han J., Park J., Kim D.H. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis 2004, 25:2165-2171.
170. Liu F., Killian J.K., Yang M., Walker R.L., Hong J.A., Zhang M., Davis S., Zhang Y., Hussain M., Xi S., Rao M., Meltzer P.A., Schrump D.S. Epigenomic alterations and gene expression profiles in respiratory epithelia exposed to cigarette smoke condensate. Oncogene 2010, 29:3650-3664.
171. Kawano H., Saeki H., Kitao H., Tsuda Y., Otsu H., Ando K., Ito S., Egashira A., Oki E., Morita M., Oda Y., Maehara Y. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma. Ann. Surg. Oncol. 2014, 21(Suppl. 4):S696-S702.
172. Wilhelm-Benartzi C.S., Houseman E.A., Maccani M.A., Poage G.M., Koestler D.C., Langevin S.M., Gagne L.A., Banister C.E., Padbury J.F., Marsit C.J. In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta. Environ. Health Perspect. 2012, 120:296-302.
173. Engel L.S., Lan Q., Rothman N. Polychlorinated biphenyls and non-hodgkin lymphoma. Cancer Epidemiol. Biomarkers Prev. 2007, 16:373-376.
174. Hardell L., Carlberg M., Hardell K., Björnfoth H., Wickbom G., Ionescu M., van B.B., Lindström G. Decreased survival in pancreatic cancer patients with high concentrations of organochlorines in adipose tissue. Biomed. Pharmacother. 2007, 61:659-664.
175. Ritchie J.M., Vial S.L., Fuortes L.J., Guo H., Reedy V.E., Smith E.M. Organochlorines and risk of prostate cancer. J. Occup. Environ. Med. 2003, 45:692-702.
176. Lee D.H., Lee I.K., Porta M., Steffes M., Jacobs D.R. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the national health and nutrition examination survey 1999-2002. Diabetologia 2007, 50:1841-1851.
177. Pathak R., Ahmed R.S., Tripathi A.K., Guleria K., Sharma C.S., Makhijani S.D., Banerjee B.D. Maternal and cord blood levels of organochlorine pesticides: association with preterm labor. Clin. Biochem. 2009, 42:746-749.
178. Cohn B.A., Wolff M.S., Cirillo P.M., Sholtz R.I. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ. Health Perspect. 2007, 115:1406-1414.
179. Weidner I.S., Moller H., Jensen T.K., Skakkebaek N.E. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ. Health Perspect. 1998, 106:793-796.
180. Rathore M., Bhatnagar P., Mathur D., Saxena G.N. Burden of organochlorine pesticides in blood and its effect on thyroid hormones in women. Sci. Total Environ. 2002, 295:207-215.
181. Mahajan R., Bonner M.R., Hoppin J.A., Alavanja M.C. Phorate exposure and incidence of cancer in the agricultural health study. Environ. Health Perspect. 2006, 114:1205-1209.
182. Van Maele-Fabry G., Libotte V., Willems J., Lison D. Review and meta-analysis of risk estimates for prostate cancer in pesticide manufacturing workers. Cancer Causes Control 2006, 17:353-373.
183. Reynolds P., Von B.J., Gunier R.B., Goldberg D.E., Hertz A., Harnly M.E. Childhood cancer and agricultural pesticide use: an ecologic study in California. Environ. Health Perspect. 2002, 110:319-324.
184. Collotta M., Bertazzi P.A., Bollati V. Epigenetics and pesticides. Toxicology 2013, 307:35-41.
185. Rusiecki J.A., Baccarelli A., Bollati V., Tarantini L., Moore L.E., Bonefeld-Jorgensen E.C. Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit. Environ. Health Perspect. 2008, 116:1547-1552.
186. Kim K.Y., Kim D.S., Lee S.K., Lee I.K., Kang J.H., Chang Y.S., Jacobs D.R., Steffes M., Lee D.H. Association of low-dose exposure to persistent organic pollutants with global DNA hypomethylation in healthy Koreans. Environ. Health Perspect. 2010, 118:370-374.
187. Huen K., Yousefi P., Bradman A., Yan L., Harley K.G., Kogut K., Eskenazi B., Holland N. Effects of age, sex, and persistent organic pollutants on DNA methylation in children. Environ. Mol. Mutagen. 2014, 55:209-222.
188. Benford D., Dinovi M., Setzer R.W. Application of the margin-of-exposure (MoE) approach to substances in food that are genotoxic and carcinogenic e.g.: Benzo[a]pyrene and polycyclic aromatic hydrocarbons. Food Chem. Toxicol. 2010, 48(Suppl. 1):S42-S48.
189. Pelkonen O., Nebert D.W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 1982, 34:189-222.
190. Stribinskis V., Ramos K.S. Activation of human long interspersed nuclear element 1 retrotransposition by benzo(a)pyrene, an ubiquitous environmental carcinogen. Cancer Res. 2006, 66:2616-2620.
191. Teneng I., Montoya-Durango D.E., Quertermous J.L., Lacy M.E., Ramos K.S. Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation. Epigenetics 2011, 6:355-367.
192. Sadikovic B., Rodenhiser D.I. Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells. Toxicol. Appl. Pharmacol. 2006, 216:458-468.
193. Yauk C.L., Polyzos A., Rowan-Carroll A., Kortubash I., Williams A., Kovalchuk O. Tandem repeat mutation, global DNA methylation, and regulation of DNA methyltransferases in cultured mouse embryonic fibroblast cells chronically exposed to chemicals with different modes of action. Environ. Mol. Mutagen. 2008, 49:26-35.
194. Salnikow K., Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 2008, 21:28-44.
195. Martinez-Zamudio R., Ha H.C. Environmental epigenetics in metal exposure. Epigenetics 2011, 6:820-827.
196. Chervona Y., Arita A., Costa M. Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium. Metallomics 2012, 4:619-627.
197. Hossain M.B., Vahter M., Concha G., Broberg K. Low-level environmental cadmium exposure is associated with DNA hypomethylation in argentinean women. Environ. Health Perspect. 2012, 120:879-884.
198. US EPA Comprehensive environmental response, compensation, and liability act (CERCLA) priority list of hazardous substances 2010, Agency for Toxic Substances and Disease Registry.
199. Bertolero F., Pozzi G., Sabbioni E., Saffiotti U. Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation. Carcinogenesis 1987, 8:803-808.
200. Ahsan H., Chen Y., Parvez F., Zablotska L., Argos M., Hussain I., Momotaj H., Levy D., Cheng Z., Slavkovich V., van G.A., Howe G.R., Graziano J.H. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the health effects of arsenic longitudinal study. Am. J. Epidemiol. 2006, 163:1138-1148.
201. Schuhmacher-Wolz U., Dieter H.H., Klein D., Schneider K. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Crit. Rev. Toxicol. 2009, 39:271-298.
202. Wang C.H., Hsiao C.K., Chen C.L., Hsu L.I., Chiou H.Y., Chen S.Y., Hsueh Y.M., Wu M.M., Chen C.J. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol. Appl. Pharmacol. 2007, 222:315-326.
203. Ray P.D., Yosim A., Fry R.C. Incorporating epigenetic data into the risk assessment process for the toxic metals arsenic, cadmium, chromium, lead, and mercury: strategies and challenges. Front. Genet. 2014, 5:201.
204. IARC Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr. Eval. Carcinog. Risks Hum. 2004, 84:1-477.
205. Straif K., Benbrahim-Tallaa L., Baan R., Grosse Y., Secretan B., El G.F., Bouvard V., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens - part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009, 10:453-454.
206. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:10907-10912.
207. Xie Y., Liu J., Benbrahim-Tallaa L., Ward J.M., Logsdon D., Diwan B.A., Waalkes M.P. Aberrant DNA methylation and gene expression in livers of newborn mice transplacentally exposed to a hepatocarcinogenic dose of inorganic arsenic. Toxicology 2007, 236:7-15.
208. Wilhelm C.S., Kelsey K.T., Butler R., Plaza S., Gagne L., Zens M.S., Andrew A.S., Morris S., Nelson H.H., Schned A.R., Karagas M.R., Marsit C.J. Implications of LINE1 methylation for bladder cancer risk in women. Clin. Cancer Res. 2010, 16:1682-1689.
209. Intarasunanont P., Navasumrit P., Waraprasit S., Chaisatra K., Suk W.A., Mahidol C., Ruchirawat M. Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Environ. Health. 2012, 11:31.
210. Lambrou A., Baccarelli A., Wright R.O., Weisskopf M., Bollati V., Amarasiriwardena C., Vokonas P., Schwartz J. Arsenic exposure and DNA methylation among elderly men. Epidemiology 2012, 23:668-676.
211. Tajuddin S.M., Amaral A.F., Fernandez A.F., Rodriguez-Rodero S., Rodriguez R.M., Moore L.E., Tardon A., Carrato A., Garcia-Closas M., Silverman D.T., Jackson B.P., Garcia-Closas R., Cook A.L., Cantor K.P., Chanock S., Kogevinas M., Rothman N., Real F.X., Fraga M.F., Malats N. Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA. Environ. Health Perspect. 2013, 121:650-656.
212. 3 causes an extra toxicity pathway via L1 retrotransposition induction. Toxicol. Lett. 2014, 229:111-117.
213. Markopoulos G., Noutsopoulos D., Mantziou S., Vartholomatos G., Monokrousos N., Angelidis C., Tzavaras T. Arsenic induces VL30 retrotransposition: the involvement of oxidative stress and heat-shock protein 70. Toxicol. Sci. 2013, 134:312-322.
214. Engström A., Michaëlsson K., Vahter M., Julin B., Wolk A., Åkesson A. Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and fractures among women. Bone 2012, 50:1372-1378.
215. Kippler M., Tofail F., Hamadani J.D., Gardner R.M., Grantham-McGregor S.M., Bottai M., Vahter M. Early-life cadmium exposure and child development in 5-year-old girls and boys: a cohort study in rural Bangladesh. Environ. Health Perspect. 2012, 120:1462-1468.
216. Sommar J.N., Svensson M.K., Björ B.M., Elmståhl S.I., Hallmans G., Lundh T., Schön S.M., Skerfving S., Bergdahl I.A. End-stage renal disease and low level exposure to lead, cadmium and mercury; a population-based, prospective nested case-referent study in Sweden. Environ. Health. 2013, 12:9.
217. National Toxicology Program. Ninth report on carcinogens, (2000).
218. Takiguchi M., Achanzar W.E., Qu W., Li G., Waalkes M.P. Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp. Cell Res. 2003, 286:355-365.
219. Huang D., Zhang Y., Qi Y., Chen C., Ji W. Global DNA hypomethylation, rather than reactive oxygen species (ROS), a potential facilitator of cadmium-stimulated K562 cell proliferation. Toxicol. Lett. 2008, 179:43-47.
220. Jiang G., Xu L., Song S., Zhu C., Wu Q., Zhang L., Wu L. Effects of long-term low-dose cadmium exposure on genomic DNA methylation in human embryo lung fibroblast cells. Toxicology 2008, 244:49-55.
221. Yuan D., Ye S., Pan Y., Bao Y., Chen H., Shao C. Long-term cadmium exposure leads to the enhancement of lymphocyte proliferation via down-regulating p16 by DNA hypermethylation. Mutat. Res. 2013, 757:125-131.
222. Ferguson A., Rimmer T. Navigating the lead laws/rules/standards for renovation and repair activities: a guide for contractors and laborers. J. Environ. Protect. 2012, 2012.
223. Levin R., Brown M.J., Kashtock M.E., Jacobs D.E., Whelan E.A., Rodman J., Schock M.R., Padilla A., Sinks T. Lead exposures in U.S. children, 2008. Implications for prevention. Environ. Health Perspect. 2008, 116:1285-1293.
224. Datta-Mitra A., Ahmed O. Ayurvedic medicine use and lead poisoning in a child: a continued concern in the United States. Clin. Pediatr. (Phila) 2014.
225. Bellinger D.C. Lead neurotoxicity and socioeconomic status: conceptual and analytical issues. Neurotoxicology 2008, 29:828-832.
226. Advisory Committee on Childhood Lead, Poisoning Prevention Low level lead exposure harms children: A renewed call for primary prevention: Report to the CDCP 2012, 1-54. ACCLPP, Atlanta, GA, USA.
227. Hernandez-Avila M., Peterson K.E., Gonzalez-Cossio T., Sanin L.H., Aro A., Schnaas L., Hu H. Effect of maternal bone lead on length and head circumference of newborns and 1-month-old infants. Arch. Environ. Health 2002, 57:482-488.
228. Centers for Disease Control and Prevention Guidelines for the identification and management of lead exposure in pregnant and lactating women 2010, US Dept of Health and Human Services, Atlanta, GA.
229. Gundacker C., Wittmann K.J., Kukuckova M., Komarnicki G., Hikkel I., Gencik M. Genetic background of lead and mercury metabolism in a group of medical students in Austria. Environ. Res. 2009, 109:786-796.
230. Sirivarasai J., Wananukul W., Kaojarern S., Chanprasertyothin S., Thongmung N., Ratanachaiwong W., Sura T., Sritara P. Association between inflammatory marker, environmental lead exposure, and glutathione S-transferase gene. Biomed. Res Int. 2013, 2013:474963.
231. Wright R.O., Schwartz J., Wright R.J., Bollati V., Tarantini L., Park S.K., Hu H., Sparrow D., Vokonas P., Baccarelli A. Biomarkers of lead exposure and DNA methylation within retrotransposons. Environ. Health Perspect. 2010, 118:790-795.
232. Pilsner J.R., Hu H., Ettinger A., Sánchez B.N., Wright R.O., Cantonwine D., Lazarus A., Lamadrid-Figueroa H., Mercado-García A., Téllez-Rojo M.M., Hernández-Avila M. Influence of prenatal lead exposure on genomic methylation of cord blood DNA. Environ. Health Perspect. 2009, 117:1466-1471.
233. Li C., Yang X., Xu M., Zhang J., Sun N. Epigenetic marker (LINE-1 promoter) methylation level was associated with occupational lead exposure. Clin. Toxicol. (Phila) 2013, 51:225-229.
234. Risher J.F. Elemental mercury and inorganic mercury compounds: Human health aspects 2003, World Health Organization. Concise International Chemical Assessment Document.
235. Swain E.B., Jakus P.M., Rice G., Lupi F., Maxson P.A., Pacyna J.M., Penn A., Spiegel S.J., Veiga M.M. Socioeconomic consequences of mercury use and pollution. Ambio 2007, 36:45-61.
236. Bose R., Onishchenko N., Edoff K., Janson Lang A.M., Ceccatelli S. Inherited effects of low-dose exposure to methylmercury in neural stem cells. Toxicol. Sci. 2012, 130:383-390.
237. Goodrich J.M., Basu N., Franzblau A., Dolinoy D.C. Mercury biomarkers and DNA methylation among Michigan dental professionals. Environ. Mol. Mutagen. 2013, 54:195-203.
238. Habibi L., Shokrgozar M.A., Tabrizi M., Modarressi M.H., Akrami S.M. Mercury specifically induces LINE-1 activity in a human neuroblastoma cell line. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2014, 759:9-20.
239. Wang T.C., Song Y.S., Wang H., Zhang J., Yu S.F., Gu Y.E., Chen T., Wang Y., Shen H.Q., Jia G. Oxidative DNA damage and global DNA hypomethylation are related to folate deficiency in chromate manufacturing workers. J. Hazard. Mater. 2012, 213-214:440-446.
240. Lou J., Wang Y., Yao C., Jin L., Wang X., Xiao Y., Wu N., Song P., Song Y., Tan Y., Gao M., Liu K., Zhang X. Role of DNA methylation in cell cycle arrest induced by cr (VI) in two cell lines. PLoS ONE 2013, 8:e71031.
241. El-Sawy M., Kale S.P., Dugan C., Nguyen T.Q., Belancio V., Bruch H., Roy-Engel A.M., Deininger P.L. Nickel stimulates L1 retrotransposition by a post-transcriptional mechanism. J. Mol. Biol. 2005, 354:246-257.
242. Brouha B., Schustak J., Badge R.M., Lutz-Prigge S., Farley A.H., Moran J.V., Kazazian H.H. Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5280-5285.
243. Lutz S.M., Vincent B.J., Kazazian H.H., Batzer M.A., Moran J.V. Allelic heterogeneity in LINE-1 retrotransposition activity. Am. J. Hum. Genet. 2003, 73:1431-1437.
244. Boissinot S., Entezam A., Young L., Munson P.J., Furano A.V. The insertional history of an active family of L1 retrotransposons in humans. Genome Res. 2004, 14:1221-1231.
245. Goodman J.I., Augustine K.A., Cunnningham M.L., Dixon D., Dragan Y.P., Falls J.G., Rasoulpour R.J., Sills R.C., Storer R.D., Wolf D.C., Pettit S.D. What do we need to know prior to thinking about incorporating an epigenetic evaluation into safety assessments?. Toxicol. Sci. 2010, 116:375-381.
246. LeBaron M.J., Rasoulpour R.J., Klapacz J., Ellis-Hutchings R.G., Hollnagel H.M., Gollapudi B.B. Epigenetics and chemical safety assessment. Mutat. Res. 2010, 705:83-95.
247. Fan T., Schmidtmann A., Xi S., Briones V., Zhu H., Suh H.C., Gooya J., Keller J.R., Xu H., Roayaei J., Anver M., Ruscetti S., Muegge K. DNA hypomethylation caused by lsh deletion promotes erythroleukemia development. Epigenetics 2008, 3:134-142.
248. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 2003, 300:489-492.
249. Prüss-Ürsün A., Corvalàn C. Preventing disease through healthy environments. Towards an estimate of the environmental burden of disease 2006, World Health Organization.